InVasc Therapeutics develops drug-based platforms for diabetes, atherosclerosis, hypertension, and cardiovascular diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Tucker
State: Georgia
Zip:
Country: United States
InVasc Therapeutics was founded in 2006 by three leading researchers at Emory University and Ohio State University. These three researchers began their fifteen-year research and clinical collaboration at Emory University. InVasc was formed to develop several platforms of drugs to combat cardiometabolic conditions such as diabetes, atherosclerosis, hypertension and cardiovascular diseases and their complications. In the spring of 2010, the Company transitioned from an early phase start up led by academic researchers to a development organization by adding two senior executives with more than 70 years of combined executive and product development experience in the pharmaceutical, medical device and biotechnology industry.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2010 | Series A | 1 | $3.1M |
Trois I Investments Industriels Internationaux Trois I Investments Industriels Internationaux |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|